UNSPSC 51282132: Metampicillin sodium

This classification denotes a penicillin antibiotic with the molecular formula C17H18N3O4S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1HE2T55NH5, chemically known as sodium (6r)-6-(d-2-methyleneamino-2-phenylacetamido)penicillanate, but more generally known as metampicillin sodium, which bears US NIH Compound Identifier 5702187. European Medicines Agency schedules metampicillin sodium or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08811MIG.

Most nations, for tariff purposes, schedule metampicillin sodium under HS 29411020. SMILES: CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3CCCCC3)N=C)C(=O)[O-])C.[NA+].

UNSPSC 51282132 Metampicillin sodium is a Commodity code that designates a specific pharmaceutical product for procurement by state and local health agencies. Recent state and local opportunities show little activity directly aligned with metampicillin sodium itself; the Illinois Department of Public Health's August 28, 2026 award through MMCAP Infuse to Chartwell Rx LLC was for Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets supplied via pharmaceutical warehouse piggyback contract, and Seminole County, Florida's June 30, 2026 IFB for Naloxone and drug deactivation systems reflects public-health emergency response procurement rather than antibiotic supply. State and local health departments, county health authorities, and community health programs are the typical issuing bodies for pharmaceutical goods at this commodity level, though the recent record shows broader health-response categories rather than narrow-spectrum antibiotic acquisition.

The geographic spread of recorded activity is limited to Illinois and Florida in the recent window, with the Illinois procurement representing a three-year statewide framework contract valued at $2,999,999.11 and the Florida opportunity a recurring annual purchase for a county health building. Neither opportunity specifically names metampicillin sodium, suggesting the code sees minimal direct procurement volume in current state and local markets, or that agencies are sourcing the product through broader pharmaceutical blanket agreements or cooperative purchasing vehicles rather than standalone solicitations. Businesses evaluating this code should monitor whether health department inventory notices, state pharmaceutical purchasing consortia such as MMCAP, or emergency preparedness directives generate dedicated metampicillin procurement in the coming quarters.